Awareness Technology — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Awareness Technology is a long-established, privately-held developer of automated benchtop analyzers for diagnostic and research laboratories. Its flagship ChemWell platform offers modular systems capable of running diverse assay types (ELISA, CLIA, biochemistry, immunoturbidimetry) on standard microwell plates, emphasizing flexibility, user-programmability, and walk-away automation. The company serves a broad but niche market across human and veterinary diagnostics, environmental monitoring, and life sciences, competing as a specialized provider of cost-effective, mid-throughput automation solutions.

DiagnosticsMedical Devices

Technology Platform

The ChemWell platform of PC-controlled, benchtop automated analyzers for ELISA, chemiluminescence (CLIA), biochemistry, and turbidimetric assays on standard microwell plates. Key features include user-programmable protocols, multi-modal detection (absorbance, luminescence), automated liquid handling, and integrated QC software.

Opportunities

Growing demand for cost-effective, flexible automation in small-to-mid-sized clinical, veterinary, and applied testing laboratories presents a significant opportunity.

Expansion into emerging markets and the continued trend of laboratory workflow consolidation further support growth potential for the company's open-system, benchtop analyzers.

Risk Factors

Intense competition from large, well-capitalized diagnostics corporations with closed, high-throughput systems poses a constant threat.

The company also faces technology obsolescence risk if it fails to keep pace with software, connectivity, and data integration trends in modern laboratories.

Competitive Landscape

Awareness Technology competes in the benchtop analyzer segment against large multinationals (e.g., Abbott, Siemens, Roche) and other specialized manufacturers. Its competitive advantage lies in offering flexible, user-programmable, open systems at a mid-range price point, serving labs that prioritize assay variety and cost control over the ultra-high throughput of larger, closed systems.

More companies in Diagnostics & Precision Medicine →More companies in United States →